Prospective Pecutaneous Coronary Intervention Registry

Condition(s) studied

Investigational drug(s) / intervention(s)

Percutaneous coronary intervention: Percutaneous Coronary Intervention Procedure

Study summary

Coronary artery disease is the most important cause of death worldwide. Treatment option for coronary artery disease is medical treatment, percutaneous coronary intervention, or coronary artery bypass surgery. Among them, the field of percutaneous coronary intervention is rapidly developing with regard to the improvement of devices, techniques, or medical treatment, leading to reduce mortality or morbidity. Until now, numerous previous studies related to the risk factors of coronary artery disease and the prognosis of patients have been conducted. However, the field of percutaneous coronary intervention is rapidly evolving, and treatment strategies are constantly being updated. Therefore, the current study sought to identify the long-term prognosis and related risk factors of patients with coronary artery disease who underwent percutaneous coronary intervention.

Eligibility

Primary outcome measure(s)

• Rates of Cardiac death or Target-vessel myocardial infarction — up to 10 years
  A composite of cardiac death or target vessel myocardial infarction
• Rates of Major adverse cardiac and cerebrovascular event — up to 10 years
  A composite of all-cause death, myocardial infarction, cerebrovascular accident, or repeat revascularization

Trial sites (1)

More Samsung Medical Center trials in South Korea

Other trials for the same condition